Advertisement Lincoln gives Anapen UK, Ireland distribution rights to Allergy Therapeutics - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lincoln gives Anapen UK, Ireland distribution rights to Allergy Therapeutics

Lincoln Medical has given the UK and Ireland distribution rights of epinephrine pen auto injector, Anapen to Allergy Therapeutics.

Produced by Lincoln, Anapen is indicated as a treatment for anaphylactic shock.

Under the five year agreement, Allergy has paid £600,000 to Lincoln.

Allergy is selling Anapen in The Netherlands since September 2010 and has also received the exclusive rights to distribute Anapen in Italy, Spain, Belgium, Poland, Argentina, Venezuela, Colombia and Chile.

The company anticipates to launch Anapen in these countries during the next 12 months, subject to regulatory approvals.